Overview

Fingolimod as a Treatment of Cerebral Edema After Intracerebral Hemorrhage

Status:
Recruiting
Trial end date:
2022-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the safety and effectiveness of a single dose of fingolimod in patients with primary spontaneous intracerebral hemorrhage (ICH).
Phase:
Early Phase 1
Details
Lead Sponsor:
Wake Forest University Health Sciences
Treatments:
Fingolimod Hydrochloride